Clinical trials
Cancer clinical trials
Below are recruiting cancer clinical trials, each written for real people, not researchers. We’re tracking 12,833 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07466602Recruiting
Using DNA to detect liver cancer return
This trial uses a blood test to check for signs of liver cancer coming back after treatment. It may help find recurrence earlier than standard scans.
Wuhan, HubeiAges 18 years+ - NCT07468851RecruitingPhase 1/Phase 2
Study of HS-10566 for high-risk bladder cancer that hasn't spread into muscle
This study tests a new treatment called HS-10566 for people with a type of bladder cancer that has not reached the muscle layer and is considered high-risk, where the usual treatments have not worked or were not an option. It aims to control the cancer and avoid the need for removing the bladder.
BeijingAges 18 years+ - NCT07465757RecruitingPhase 2
Study of alisertib and paclitaxel for small cell lung cancer
This trial tests a combination of two drugs, alisertib and paclitaxel, for people with small cell lung cancer (SCLC) who have already had at least one type of platinum chemotherapy and an immunotherapy. The goal is to see if this treatment can help shrink tumors or slow the cancer's growth.
AlicanteAges 18 years+ - NCT07470853RecruitingPhase 1
Study of HWK-016 for advanced ovarian or endometrial cancer
This trial tests a new drug called HWK-016, which is designed to target and deliver medicine directly to cancer cells that have a specific marker (MUC16). It is for people with advanced ovarian or endometrial cancer to see if it can shrink tumors or slow their growth.
Little Rock, ArkansasAges 18 years+ - NCT06788366Recruiting
AI tool to predict outcomes in metastatic lung cancer
This trial is testing whether artificial intelligence can help predict how well people with advanced non-small cell lung cancer (NSCLC) respond to immunotherapy or chemo-immunotherapy. If you have stage IV NSCLC and have started this treatment, your data may help build a better prediction tool.
MilanAges 18 years+ - NCT06627036RecruitingPhase 4
Dermoscopy vs standard marking for skin cancer removal
This trial compares two ways of marking skin before removing a non-melanoma skin cancer: using a special magnifying tool called a dermoscope versus the standard method. The goal is to see which method helps remove the cancer completely the first time.
HullAges 18 years+ - NCT07469761Recruiting
Personalized care plan for frail cancer patients
This trial tests a special care plan designed for people with advanced cancer who are frail. The goal is to see if this personalized approach helps improve quality of life and support.
Milan, LombardyAges 18 years+ - NCT07470658Enrolling by invitation
Surveillance after positive FIT and normal colonoscopy
This trial studies the best way to follow up with people who had a positive FIT stool test (high blood level) but a normal colonoscopy. It aims to find the right schedule for future screening to catch any problems early.
TaipeiAges 45–74 - NCT07467083RecruitingPhase 3
Nurse-led symptom management for head and neck cancer radiation
This trial tests a nurse-led program to help manage symptoms before they start, for people with head and neck cancer who are getting radiation therapy. The goal is to improve quality of life during treatment.
Chengdu, SichuanAges 18–80 - NCT07463300Recruiting
AI Study for Lung Cancer Type and Genetics via PET/CT
This study uses an AI system that looks at your PET/CT scan images to figure out the exact type and genetic makeup of your non-small cell lung cancer. The goal is to improve how doctors classify and treat your cancer without needing extra invasive tests.
Guangzhou, GuangdongAges 18 years+ - NCT07471776RecruitingPhase 2
Predicting ADC treatment response with PET scans in advanced breast cancer
This study uses special PET scans to see if a type of targeted therapy called an anti-TROP2 ADC will work well for your advanced breast cancer. The therapy is already part of your standard care; the scans help doctors understand how your tumor responds.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07466238Recruiting
Chemo into the liver plus IV chemo for bile duct cancer
This trial is testing a treatment plan that first delivers chemotherapy directly into the liver (through a thin tube) along with standard IV chemotherapy. The goal is to shrink the tumor enough to allow for surgery or less aggressive treatment later. It is for people with bile duct or gallbladder cancer that has not spread far.
BeijingAges 18–80 - NCT07469267Recruiting
Armpit radiation vs more surgery for early breast cancer with node spread
This trial tests whether radiation to the lower armpit (level I-II axilla) works as well as more extensive surgery for women with early-stage breast cancer that has spread to one or two sentinel lymph nodes (with cancer size > 2 mm). It aims to find a gentler treatment that still keeps the cancer from coming back.
Guiyang, GuizhouAges 18 years+ - NCT07463547Enrolling by invitation
Study on wearables for tracking symptoms in cancer survivors
This trial tests if a wearable device paired with a smartphone app can help monitor symptoms in cancer survivors. The goal is to improve how we track and manage symptoms during and after treatment.
Birmingham, AlabamaAges 18 years+ - NCT07467824Recruiting
Exercise and support before and after breast cancer treatment
This trial tests whether a program of supervised exercise and full follow-up before and after breast cancer treatment can improve recovery and quality of life for women with early-stage breast cancer.
Valladolid, ValladolidAges 18–65 - NCT07465848Recruiting
Testing telomere measurement to help diagnose lung cancer
This study uses a simple blood test to measure telomeres (parts of your DNA) to see if it can help detect lung cancer earlier. Researchers will compare results from people with lung cancer, heavy smokers, and low-risk individuals to improve diagnosis.
Elche, AlicanteAges 45 years+ - NCT07463092Recruiting
Creatine and exercise for muscle health in prostate cancer
This study tests whether taking creatine and doing weightlifting exercises can help men with prostate cancer who have been on hormone therapy for at least 6 months to improve muscle strength and size. It lasts 12 weeks and involves supervised workouts three times per week.
São Paulo, São PauloAges 40 years+ - NCT07464626Recruiting
Art therapy for anxiety and sleep in colorectal cancer patients
This study compares virtual and in-person art therapy to help reduce anxiety, improve psychological well-being, and enhance sleep quality for people with colorectal cancer who are receiving chemotherapy.
Izmir, BalçovaAges 18 years+ - NCT07471451Recruiting
Eating and quality of life after jaw reconstruction
This study looks at how well people can chew, eat, and speak after having jaw or face reconstruction due to cancer. It aims to understand how these functions affect your daily life and happiness.
Clermont-FerrandAges 18 years+ - NCT06775977Recruiting
Ultrasound contrast for bladder cancer staging
This trial uses a special ultrasound with contrast dye to get a clearer picture of bladder cancer before any treatment. It aims to improve how doctors determine the stage of the cancer, which helps guide the best treatment plan.
Guangzhou, GuangdongAges 18–75 - NCT06791083RecruitingPhase 2
Envafolimab, Fruquintinib, and chemo before gastric cancer surgery
This trial tests a combination of two targeted drugs (Envafolimab and Fruquintinib) plus chemotherapy given before surgery for certain types of stomach cancer. The goal is to see if this approach can shrink the tumor and improve outcomes.
Fuzhou, FujianAges 18–75 - NCT06791148RecruitingPhase 2
Low-dose radiation plus chemo and immunotherapy for advanced stomach cancer
This trial tests a combination of low-dose radiation, chemotherapy, and an immunotherapy drug (AK112) for people with advanced stomach or gastroesophageal junction cancer that has progressed after first-line treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Nanjing, JiangsuAges 18–75 - NCT06792604Recruiting
Methylation test for anal cancer screening
This study is testing a new way to screen for anal cancer by looking at DNA methylation in cells collected from the anus. It may help people at higher risk for anal cancer find out earlier if they need further tests.
Paris, Île-de-France RegionAges 18 years+ - NCT06792162RecruitingPhase 2
Immunotherapy and targeted therapy trial for advanced gastric cancer
This trial tests a combination of two drugs: carilizumab (an immunotherapy) and apatinib (a targeted therapy) for patients with unresectable stage III or IV gastric cancer that has a specific DNA repair problem (dMMR). The goal is to see if this treatment can help shrink tumors and improve outcomes.
BeijingAges 18 years+
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cancer?
- Yes. Clin2 currently lists 12,833 recruiting cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Beyond the search
We also like to point to nonprofits doing real good in this area. We aren’t affiliated with them — we just admire the work.
- Stand Up To CancerPeople facing cancer across many types, through the research that leads to better treatments.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.